Suppr超能文献

非受体酪氨酸激酶 2 在人乳腺癌区域淋巴结转移过程中表达水平最低。

Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis.

机构信息

Department of Chemistry and Biochemistry and Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306-4390, USA.

出版信息

Clin Exp Metastasis. 2012 Feb;29(2):143-53. doi: 10.1007/s10585-011-9437-1. Epub 2011 Nov 25.

Abstract

Almost half of breast Ductal Carcinoma in situ are likely to remain non threatening in situ lesions with no invasion to the surrounding stroma and no metastases. The majority of focal disruptions in myoepithelial (ME) cell layers indicative of invasion onset were found to be overlying epithelial cell clusters with no or substantially reduced estrogen receptor α (ERα) expression. Here we report the down-regulation of tyrosine kinase-2 (TYK2) and up-regulation of strumpellin expression, among other proteins in ERα(-) cells located at disrupted ME layers compared to adjacent ERα(+) cells overlying an intact myoepithelial layer. ERα(+) and ERα(-) cells were microdissected from the same in vivo human breast cancer tissues, proteins were extracted and separated utilizing Differential in-Gel Electrophoresis followed by trypsin digestion, MALDI-TOF analysis, and protein identification. Proteins expressed by ERα(-) cell clusters were found to express higher levels of strumpellin that binds to valosin-containing protein (VCP) to slow-down wound closure and promote growth; and lower levels of TYK2, a jak protein necessary for lineage specific differentiation. TYK2 levels were further analyzed by immunohistochemistry in a cohort composed of 70 patients with broad clinical characteristics. TYK2 levels were minimal in TxN1M0 breast cancers which is the stage where the initial regional lymph node metastasis is observed. Our data highlight the role of TYK2 downregulation in breast cancer cell de-differentitation and initiation of regional metastasis. In addition, the aggressiveness of the ERα(-) cell clusters compared to ERα(+) ones present in the same duct of the same patient was confirmed.

摘要

几乎一半的乳腺导管原位癌(DCIS)可能仍然是非侵袭性原位病变,没有周围基质的浸润,也没有转移。大多数提示侵袭开始的肌上皮(ME)细胞层的局灶性破坏被发现覆盖有上皮细胞簇,这些细胞簇几乎没有或显著减少雌激素受体α(ERα)的表达。在这里,我们报告了在与相邻完整肌上皮层上的 ERα(+)细胞相比,位于破坏的 ME 层中的 ERα(-)细胞中酪氨酸激酶-2(TYK2)的下调和 strumpellin 表达的上调,以及其他蛋白的下调。ERα(+)和 ERα(-)细胞是从相同的体内人乳腺癌组织中微切割的,利用差异凝胶电泳(DIGE)后进行胰蛋白酶消化、MALDI-TOF 分析和蛋白质鉴定,提取和分离蛋白质。发现 ERα(-)细胞簇表达的蛋白质表达更高水平的 strumpellin,它与含有缬氨酸的蛋白(VCP)结合,以减缓伤口闭合并促进生长;并且 TYK2 水平较低,TYK2 是一种 jak 蛋白,对于谱系特异性分化是必需的。在由 70 名具有广泛临床特征的患者组成的队列中,通过免疫组织化学进一步分析了 TYK2 水平。在 TxN1M0 乳腺癌中,TYK2 水平最低,这是观察到初始区域淋巴结转移的阶段。我们的数据强调了 TYK2 下调在乳腺癌细胞去分化和启动区域转移中的作用。此外,与同一患者同一导管中的 ERα(+)细胞相比,ERα(-)细胞簇的侵袭性得到了证实。

相似文献

1
Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis.
Clin Exp Metastasis. 2012 Feb;29(2):143-53. doi: 10.1007/s10585-011-9437-1. Epub 2011 Nov 25.
4
Janus kinase 2--a novel negative regulator of estrogen receptor α function.
Cell Signal. 2012 Jan;24(1):151-61. doi: 10.1016/j.cellsig.2011.08.016. Epub 2011 Sep 1.
10
Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
Breast Cancer Res. 2018 May 2;20(1):35. doi: 10.1186/s13058-018-0963-5.

引用本文的文献

1
TYK2 in Cancer Metastases: Genomic and Proteomic Discovery.
Cancers (Basel). 2021 Aug 19;13(16):4171. doi: 10.3390/cancers13164171.
2
Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
J Inflamm Res. 2021 Jan 14;14:97-114. doi: 10.2147/JIR.S284889. eCollection 2021.
3
TYK2: An Upstream Kinase of STATs in Cancer.
Cancers (Basel). 2019 Nov 5;11(11):1728. doi: 10.3390/cancers11111728.
5
Establishing the role of tyrosine kinase 2 in cancer.
Oncoimmunology. 2013 Jan 1;2(1):e22840. doi: 10.4161/onci.22840.
6
Analysis of tubulin alpha-1A/1B C-terminal tail post-translational poly-glutamylation reveals novel modification sites.
J Proteome Res. 2012 Mar 2;11(3):1913-23. doi: 10.1021/pr2011044. Epub 2012 Feb 15.

本文引用的文献

2
Putative biomarkers and targets of estrogen receptor negative human breast cancer.
Int J Mol Sci. 2011;12(7):4504-21. doi: 10.3390/ijms12074504. Epub 2011 Jul 13.
4
Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle.
Cancer Res. 2011 Feb 15;71(4):1219-28. doi: 10.1158/0008-5472.CAN-10-2294. Epub 2011 Feb 8.
5
Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26.
J Cancer. 2010 Jun 2;1:14-22. doi: 10.7150/jca.1.14.
7
Regulatory T cells and breast cancer: implications for immunopathogenesis.
Cancer Metastasis Rev. 2010 Dec;29(4):569-79. doi: 10.1007/s10555-010-9247-y.
10
Commentary on H. Ide et al., "Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells".
Biochem Biophys Res Commun. 2008 Feb 22;366(4):869-70. doi: 10.1016/j.bbrc.2007.12.017. Epub 2007 Dec 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验